Fatty acid desaturase 1 gene polymorphisms control human hepatic lipid composition
Open Access
- 14 August 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 61 (1) , 119-128
Abstract
Fatty acid desaturase (FADS) genes and their variants have been associated with multiple metabolic phenotypes, including liver enzymes and hepatic fat accumulation, but the detailed mechanism remains unclear. We aimed to delineate the role of FADSs in modulating lipid composition in human liver. We performed a targeted lipidomic analysis of a variety of phospholipids, sphingolipids, and ceramides among 154 human liver tissue samples. The associations between previously genome‐wide association studies (GWASs)‐identified six FADS single‐nucleotide polymorphisms (SNPs), and these lipid levels as well as total hepatic fat content (HFC) were tested. The potential function of these SNPs in regulating transcription of three FADS genes (FADS1, FADS2, and FADS3) in the locus was also investigated. We found that though these SNPs were in high linkage disequilibrium (r 2 > 0.8), the rare alleles of these SNPs were consistently and significantly associated with the accumulation of multiple long‐chain fatty acids (LCFAs), with C47H85O13P (C36:4), a phosphatidylinositol (PI), and C43H80O8PN (C38:3), a phosphatidylethanolamine (PE), reached the Bonferroni corrected significance (P < 3 × 10−4). Meanwhile, these SNPs were significantly associated with increased ratios between the more saturated and relatively less saturated forms of LCFAs, especially between PEs, PIs, and phosphatidylcholines (PCs; P ≤ 3.5 × 10−6). These alleles were also associated with increased total HFC (P < 0.05). Further analyses revealed that these alleles were associated with decreased hepatic expression of FADS1 (P = 0.0018 for rs174556), but not FADS2 or FADS3 (P > 0.05). Conclusion: Our findings revealed critical insight into the mechanism underlying FADS1 and its polymorphisms in modulating hepatic lipid deposition by altering gene transcription and controlling lipid composition in human livers. (Hepatology 2015;61:119–128)Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (DK090437)
- Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University (Startup)
This publication has 44 references indexed in Scilit:
- Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasmaNature Genetics, 2011
- Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trialArchives of Disease in Childhood, 2011
- Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease riskExperimental Biology and Medicine, 2010
- Does genetic variation in the Δ6-desaturase promoter modify the association between α-linolenic acid and the prevalence of metabolic syndrome?The American Journal of Clinical Nutrition, 2009
- Lower estimates of δ-5 desaturase and elongase activity are related to adverse profiles for several metabolic risk factors in young Japanese womenNutrition Research, 2008
- Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human SerumPLOS Genetics, 2008
- Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver diseaseDigestive and Liver Disease, 2008
- Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolismProceedings of the National Academy of Sciences, 2007
- Prolonged n‐3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non‐alcoholic fatty liver disease: a pilot studyAlimentary Pharmacology & Therapeutics, 2006
- STRUCTURE, FUNCTION, AND DIETARY REGULATION OF Δ6, Δ5, AND Δ9 DESATURASESAnnual Review of Nutrition, 2004